Cargando…

Use of Ceftazidime-Avibactam in the Treatment of Clinical Syndromes With Limited Treatment Options: A Retrospective Study

Background With rising trends of multi-drug organism infections and the limited availability of new antimicrobials, management of such cases has become a hassle for the clinician. Ceftazidime-Avibactam (CEF-AVI) is evolving as an effective alternative to polymyxins in the management of Carbapenem-Re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Radha, Sneha, Warrier, Anup R, Wilson, Arun, Prakash, Shilpa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Infectious Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918332/ https://www.ncbi.nlm.nih.gov/pubmed/36788880 http://dx.doi.org/10.7759/cureus.33623

Ejemplares similares

Clinical Outcomes in Carbapenem-Resistant Enterobacteriaceae Infections Treated With Ceftazidime-Avibactam: A Single-Center Observational Study
por: Rathish, Balram, et al.
Publicado: (2021)

How to Save Half a Million Dollars: An Antimicrobial Stewardship Program in a Tertiary Care Center
por: Rathish, Balram, et al.
Publicado: (2019)

Early and Appropriate Use of Ceftazidime-Avibactam in the Management of Multidrug-Resistant Gram-Negative Bacterial Infections in the Indian Scenario
por: Swaminathan, Subramanian, et al.
Publicado: (2022)

A Case of New Delhi Metallo-β-Lactamases (NDM) Citrobacter sedlakii Osteomyelitis Successfully Treated With Ceftazidime-Avibactam and Aztreonam
por: Rubnitz, Zachary A, et al.
Publicado: (2022)

OXA-48 Dominance Meets Ceftazidime-Avibactam: A Battle Against Life-Threatening Carbapenem-Resistant Klebsiella pneumoniae Infections in the Intensive Care Unit
por: Önal, Uğur, et al.
Publicado: (2023)

Microbiological Spectrum of Neutropenic Sepsis in Cancer Patients Admitted to a Tertiary Health Care Centre
por: John, Kevin R, et al.
Publicado: (2023)

A Bundled Approach to Pulmonary Tuberculosis Testing: Experience from a Tertiary Care Centre in South India
por: Rathish, Balram, et al.
Publicado: (2019)

Ceftazidime-Avibactam for the Treatment of Serious Gram-Negative Infections with Limited Treatment Options: A Systematic Literature Review
por: Soriano, Alex, et al.
Publicado: (2021)

Lyme Disease and Post-treatment Lyme Disease Syndrome: Current and Developing Treatment Options
por: Talbot, Norris C, et al.
Publicado: (2023)

Ceftazidime-avibactam
por: Matesanz, Mayra, et al.
Publicado: (2021)

Ceftazidime-avibactam
por: Herrero, Francisco Sanz
Publicado: (2022)

Ceftazidime-Resistant Burkholderia Cepacia: An Unusual Case in a Pregnant Patient
por: Ishtiaq, Rizwan, et al.
Publicado: (2017)

Treatment of Carbapenem-Resistant Enterobacteriaceae Infections with Ceftazidime-Avibactam
por: Rahmati, Elham, et al.
Publicado: (2017)

Ceftazidime/avibactam for specified infections
Publicado: (2020)

Identification of a Novel Ceftazidime-Avibactam-Resistant KPC-2 Variant, KPC-123, in Citrobacter koseri Following Ceftazidime-Avibactam Treatment
por: Wang, Lin, et al.
Publicado: (2022)

Treatment options and barriers to case management of neonatal pneumonia in India: a protocol for a scoping review
por: Nair, N Sreekumaran, et al.
Publicado: (2017)

Factors associated with recruitment success in the phase 2a study of aztreonam–avibactam development programme: a descriptive qualitative analysis among sites in Spain
por: Jimenez-Rodriguez, Rosa M, et al.
Publicado: (2022)

Review of Ceftazidime-Avibactam for the Treatment of Infections Caused by Pseudomonas aeruginosa
por: Daikos, George L., et al.
Publicado: (2021)

Ceftazidime–Avibactam for the Treatment of Multidrug-Resistant Pathogens: A Retrospective, Single Center Study
por: Di Pietrantonio, Maria, et al.
Publicado: (2022)

Clinical use of remdesivir in COVID-19 treatment: a retrospective cohort study
por: Pham, Hong Tham, et al.
Publicado: (2023)

Acetylcysteine increases sensitivity of ceftazidime-avibactam–resistant enterobacterales with different enzymatic resistance to ceftazidime-avibactam in vitro and in vivo
por: Huang, Zeyu, et al.
Publicado: (2023)

Clinical Features, Radiological Findings, and Treatment Outcomes in Patients with Pulmonary Nocardiosis: A Retrospective Analysis
por: Yadav, Prakrati, et al.
Publicado: (2021)

Acute Periprosthetic Hip Joint Infection Caused by Multidrug-Resistant Acinetobacter Baumannii: Is Debridement, Antibiotics, Irrigation, and Implant Retention a Viable Treatment Option?
por: Vasiliadis, Angelo V, et al.
Publicado: (2021)

Ceftolozane/tazobactam and ceftazidime/avibactam for the treatment of complicated intra-abdominal infections
por: Goodlet, Kellie J, et al.
Publicado: (2016)

Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae
por: Alraddadi, Basem M., et al.
Publicado: (2019)

Ceftazidime–Avibactam versus Meropenem for the Treatment of Complicated Intra-Abdominal Infections
por: Tan, Che-Kim, et al.
Publicado: (2019)

Limited access to hepatitis B/C treatment among vulnerable risk populations: an expert survey in six European countries
por: Falla, Abby M., et al.
Publicado: (2017)

National treatment outcome and predictors of death and treatment failure in multidrug-resistant tuberculosis in Ethiopia: a 10-year retrospective cohort study
por: Tola, Habteyes, et al.
Publicado: (2021)

Carbapenem-Resistant Enterobacteriaceae: A Retrospective Review of Presentation, Treatment, and Clinical Outcomes in a Tertiary Care Referral Hospital
por: Al Khamis, Mohammed, et al.
Publicado: (2022)

Cost of illness in patients with post-treatment Lyme disease syndrome in Belgium
por: Willems, Ruben, et al.
Publicado: (2023)

Epidemiology of tuberculosis and treatment outcomes among children in Pakistan: a 5 year retrospective study
por: Laghari, Madeeha, et al.
Publicado: (2018)

Ceftazidime-Avibactam Combination Therapy Compared to Ceftazidime-Avibactam Monotherapy for the Treatment of Severe Infections Due to Carbapenem-Resistant Pathogens: A Systematic Review and Network Meta-Analysis
por: Fiore, Marco, et al.
Publicado: (2020)

Induced Native Phage Therapy for the Treatment of Lyme Disease and Relapsing Fever: A Retrospective Review of First 14 Months in One Clinic
por: Jernigan, David A, et al.
Publicado: (2021)

Acute Myeloid Leukemia in a Patient With Human Immunodeficiency Virus-Related High-Risk Myelodysplastic Syndrome
por: Bijoy, Sneha, et al.
Publicado: (2022)

The limits of techne and episteme()
por: Wears, Robert L
Publicado: (2004)

COVID-19 and Kidney Disease (KD): A Retrospective Investigation in a Rural Southwestern Missouri Region Patient Population
por: Kowalski, Kailey J, et al.
Publicado: (2023)

Incidence, time and determinants of tuberculosis treatment default in Yaounde, Cameroon: a retrospective hospital register-based cohort study
por: Pefura Yone, Eric Walter, et al.
Publicado: (2011)

Retrospective cohort study to assess the association between treatment with tocilizumab and mortality among mechanically ventilated patients with COVID-19
por: Skarbinski, Jacek, et al.
Publicado: (2022)

Molecular mechanisms underlying bacterial resistance to ceftazidime/avibactam
por: Xiong, Luying, et al.
Publicado: (2022)

Ceftazidime/Avibactam Resistance in Carbapenemase-Producing Klebsiella pneumoniae
por: Cui, Qiaozhen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jbqd8nfemd7jiv0i8s6ogvos39